产品标题 |
产品货号 |
产品规格 |
厂家 |
Human Breast; Tumor of breast, phyllodes from ORIGENE TECHNOLOGIES | CS621015 | 5x5um | ORIGENE TECHNOLOGIES |
Human BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) (BRF1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP313148 | 20 ug | ORIGENE TECHNOLOGIES |
Human BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like (BRF2) from ORIGENE TECHNOLOGIES | TP302314 | 20 ug | ORIGENE TECHNOLOGIES |
Dynactin 1 (p150, glued homolog, Drosophila) (DCTN1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427531 | 100 ug | ORIGENE TECHNOLOGIES |
Dynactin 1 (p150, glued homolog, Drosophila) (DCTN1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418225 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin binding protein (DNMBP) from ORIGENE TECHNOLOGIES | LY414696 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1 (DNM1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418003 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1 (DNM1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423862 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 2 (DNM2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423697 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 2 (DNM2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423698 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 2 (DNM2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY417632 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 2 (DNM2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY429232 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 3 (DNM3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402450 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1-like (DNM1L), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402138 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1-like (DNM1L), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416000 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1-like (DNM1L), transcript variant 3 from ORIGENE TECHNOLOGIES | LY417132 | 100 ug | ORIGENE TECHNOLOGIES |
Dynamin 1-like (DNM1L), transcript variant 3 from ORIGENE TECHNOLOGIES | LY429263 | 100 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Granuloma of lymph node from ORIGENE TECHNOLOGIES | CS621282 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Granuloma of lymph node from ORIGENE TECHNOLOGIES | CS621283 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Granuloma of lymph node from ORIGENE TECHNOLOGIES | CS631695 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Hyperplasia of lymph node from ORIGENE TECHNOLOGIES | CS548209 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Hyperplasia of lymph node, atypical from ORIGENE TECHNOLOGIES | CS606293 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Inflammation of lymph node, chronic from ORIGENE TECHNOLOGIES | CS603349 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Inflammation of lymph node, chronic from ORIGENE TECHNOLOGIES | CS603350 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS804765 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617685 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617686 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617687 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617688 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617689 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617690 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS702992 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS510228 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS510232 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS536230 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphadenopathy, dermatopathic from ORIGENE TECHNOLOGIES | CS710964 | 5x5um | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565757 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565795 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565818 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565850 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565851 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565506 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565612 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565767 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565768 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565803 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, large B-cell, diffuse (protein lysate) from ORIGENE TECHNOLOGIES | CP565815 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node; Lymphoma, lymphoplasmacytic (protein lysate) from ORIGENE TECHNOLOGIES | CP565838 | 150 ug | ORIGENE TECHNOLOGIES |
Human Lymph node-Lymphoma, peripheral T-cell from ORIGENE TECHNOLOGIES | CS812117 | n/a | ORIGENE TECHNOLOGIES |
Human Lymph node; Malignant melanoma, metastatic (protein lysate) from ORIGENE TECHNOLOGIES | CP517735 | 150 ug | ORIGENE TECHNOLOGIES |